Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aethlon Medical (AEMD – Research Report) and Actinium Pharmaceuticals (ATNM – Research Report).
Aethlon Medical (AEMD)
Maxim Group analyst Anthony Vendetti maintained a Hold rating on Aethlon Medical yesterday. The company’s shares closed last Thursday at $0.40, close to its 52-week low of $0.23.
According to TipRanks.com, Vendetti has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The the analyst consensus on Aethlon Medical is currently a Hold rating.
See the top stocks recommended by analysts >>
Actinium Pharmaceuticals (ATNM)
In a report released today, Yuan Zhi from B.Riley Financial reiterated a Buy rating on Actinium Pharmaceuticals, with a price target of $20.00. The company’s shares closed last Thursday at $7.15.
According to TipRanks.com, Zhi ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on Actinium Pharmaceuticals is a Strong Buy with an average price target of $31.80, a 331.5% upside from current levels. In a report released yesterday, JonesTrading also maintained a Buy rating on the stock with a $24.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AEMD:
